We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
BlueGnome Launches “Upgrade me” Plan to Help Laboratories Scale up arrayCGH
Product News

BlueGnome Launches “Upgrade me” Plan to Help Laboratories Scale up arrayCGH

BlueGnome Launches “Upgrade me” Plan to Help Laboratories Scale up arrayCGH
Product News

BlueGnome Launches “Upgrade me” Plan to Help Laboratories Scale up arrayCGH


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "BlueGnome Launches “Upgrade me” Plan to Help Laboratories Scale up arrayCGH"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

BlueGnome announced a program designed specifically to meet the needs of laboratories that are looking to scale up the volume of their arrayCGH investigations. The new “Upgrade me” plan specifically benefits laboratories that have been using 2x105K and 4x44K oligo arrays, and wish to improve their data storage, analysis and interpretation capabilities.

Central to the plan is the adoption of BlueGnome’s BlueFuse Multi software. BlueFuse Multi combines automated data analysis with a scalable laboratory database and so provides a centralized repository around which an efficient laboratory workflow may be planned.

Critically BlueFuse Multi enables each new case to be visualized against summary tracks of all other imbalances in the database in order to identify recurrent regions of benign copy number variation or locate samples which share low frequency imbalances.

Tony Lialin, Director of North American sales, explained, “ArrayCGH data is expensive to produce and represents a major investment by cytogenetics laboratories. However even though this data is held electronically it’s impossible for a laboratory director to easily identify samples which share the same imbalance or deleted gene. We are offering the labs who join the Upgrade Me programme the opportunity to realize the full value of this investment by building for them a comprehensive laboratory database which can be used to transform the interpretation of future results.”
Advertisement